Our experience
The EATC4Children has a breadth and depth of experience across the entire clinical translational pathway that is of value to our industrial and academic partners to deliver on life-changing early phase clinical trials. That experience covers:
Biomedical research
- Molecular identification and discovery
- Epigenetic profiling
- Whole genome sequencing, WES, Panel NG sequencing
- Biomarker identification and development
- Genome modification
- Transcriptomics including statial transcriptomics
- Preclinical model systems study design
- Proteomics
- PPIE
- Clinical Trials.
PPIE
- Disease impact on life advice
- PPI training and workshops
- Promoting engagement and awareness of PPI
- Supporting patient parent involvement plans in study design
- Patient group identification.
Clinical trials
- Chief investigator experience
- Principal investigator experience
- Post-marketing surveillance requirements
- Advice on regulatory obligations
- Contributing registries (clinical trials and post marketing).
We not only work with industry partners to design and deliver novel clinical trials for children, but we are also involved in investigator-led clinical trials which have industry funding. Some of our investigator-led trial funding partners include Merck, Novartis and Pfizer.
Through other initiatives, like the Cluster consortium, we also engage with a range of industry partners like Sobi, UCB, Pfizer, Glaxo Smith Kline (GSK) and AbbVie.
Collaborate with us
If you are looking to collaborate with the EATC4Children, please contact us: eatc@liverpool.ac.uk
Requests for information will receive a response within 14 working days. If a query needs a response more quickly than 14 days, please let us know in the request and we will do our best to accommodate this.
Back to: Experimental Arthritis Treatment Centre for Children